You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas
HUTCHMED receives milestone payment from Takeda for FRUZAQLA sales
Login
Username:

Password:


Related Headlines

OncoHost named Gold Winner in 2025 Merit Awards for Healthcare

Innovent Biologics and Takeda sign global strategic partnership

TransThera publishes clinical results from US-based Phase 2 trial of tinengotinib in CCA

Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase

bioMérieux launches equine endocrinology tests to expand point-of-care diagnostics

LabGenius and Sanofi launch AI-driven collaboration on antibody optimisation

Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio

Orsini chosen as specialty pharmacy partner for ITVISMA (onasemnogene abeparvovec-brve)

Yuyu Pharma invests in Dalan Animal Health

Avetra unveils site-centric CRO operating model

Neola Medical secures US patent for disposable lung monitoring probes

Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302

Mitsubishi Tanabe Pharma America changes name

OncoPrecision's ONC001 data selected for presentation at 67th ASH Annual Meeting and Exposition

Polarean expands XENOVIEW 3T Coil access with Philips compatibility

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025